Insmed former officer lists $1.12M in shares for sale
The remarks tie the stock-plan shares to tax withholding upon restricted-stock-unit vesting and related broker fees.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Sara Bonstein, a former officer of INSMED Inc. (INSM), reported 10,261 common shares for sale through Merrill Lynch, with an approximate sale date of November 3, 2026. The securities information lists an aggregate market value of $1,121,629. Her remarks state that shares were sold to satisfy tax withholding upon vesting of Restricted Stock Units and to cover related broker fees.
Key Figures
Key Terms
Rule 144 regulatory
Restricted Stock Units financial
tax withholding obligations financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.